Lafayette Instrument, LLC, a leading global manufacturer of scientific instrumentation equipment for the life sciences, polygraph and human evaluation markets, today announced that it has acquired ...

DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the treatment of serious and life-threatening conditions ...

NEW YORK and BOCA RATON, Fla., Nov. 25, 2024 /PRNewswire/ -- Lafayette Instrument, LLC, a leading global manufacturer of scientific instrumentation equipment for the life sciences, polygraph and ...

NEW YORK and BOCA RATON, Fla., Nov. 25, 2024 /PRNewswire/ -- Lafayette Instrument, LLC, a leading global manufacturer of scientific instrumentation equipment for the life sciences, polygraph and ...

CUPERTINO, Calif., Nov. 25, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the treatment ...

DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million. Nov. 25, 2024 6:00 AM ET DURECT Corporation (DRRX) CUPERTINO, ...

NEW YORK and BOCA RATON, Fla., Nov. 25, 2024 /PRNewswire/ -- Lafayette Instrument, LLC, a leading global manufacturer of scientific instrumentation equipment for the life sciences, polygraph and ...

CUPERTINO, Calif., Nov. 25, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the ...